海尔生物：股东海创睿拟减持不超过0.85%

Group 1 - The core point of the article is that Qingdao Haichuangrui Equity Investment Fund Center (Limited Partnership), a shareholder holding 10.14% of Haier Bio, plans to reduce its stake by up to 2.6902 million shares, which represents 0.85% of the company's total share capital, due to funding needs [1] - The reduction period is set from March 3, 2026, to June 2, 2026, and the shareholder currently holds 32.1037 million shares, all acquired before the IPO [1] - As of the announcement date, the actual controller and concerted parties collectively hold 141 million shares, accounting for 44.67%, and have not reduced their holdings since the company's listing, indicating that the reduction plan will not lead to a change in control [1]